Jean Ulrick
National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
Immunodeficiency and Autoimmune Disorders, Chemokine receptors and signaling, Immune Cell Function and Interaction, SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses
Most-Cited Works
- → The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome(2011)147 cited
- → A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor(2014)139 cited
- → Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency(2007)99 cited
- → Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity(2021)94 cited
- → Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis(2010)85 cited
- → WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4(2012)79 cited
- → AMD3100 is a potent antagonist at CXCR4R334X, a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome(2010)67 cited
- → Sarcoidosis in Chronic Granulomatous Disease(2006)43 cited
- → WHIM Syndrome Caused by Waldenström’s Macroglobulinemia-Associated Mutation CXCR4 L329fs(2016)31 cited
- → Skin ulcers and disseminated abscesses are characteristic of Serratia marcescens infection in older patients with chronic granulomatous disease(2009)25 cited